The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]
Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC. Clin Interv Aging. 2015;10:1421–1429.On page 1423, Figure 2 Citicoline’s metabolic pathways, please note that this figure has been modified to include: Adibhatla RM, Hatcher JF, Dempsey RJ. Effects of citicolin...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7dae5f0708694c12a78b84b1504d1d15 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7dae5f0708694c12a78b84b1504d1d15 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7dae5f0708694c12a78b84b1504d1d152021-12-02T07:29:19ZThe role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]1178-1998https://doaj.org/article/7dae5f0708694c12a78b84b1504d1d152015-10-01T00:00:00Zhttps://www.dovepress.com/corrigendum-the-role-of-citicoline-in-cognitive-impairment-pharmacolog-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC. Clin Interv Aging. 2015;10:1421–1429.On page 1423, Figure 2 Citicoline’s metabolic pathways, please note that this figure has been modified to include: Adibhatla RM, Hatcher JF, Dempsey RJ. Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia. Stroke. 2001;32(10):2376–2381.Read the original articleGareri PCastagna ACotroneo AMPutignano SDe Sarro GBruni ACDove Medical PressarticleGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 10, Pp 1625-1626 (2015) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Geriatrics RC952-954.6 |
spellingShingle |
Geriatrics RC952-954.6 Gareri P Castagna A Cotroneo AM Putignano S De Sarro G Bruni AC The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum] |
description |
Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC. Clin Interv Aging. 2015;10:1421–1429.On page 1423, Figure 2 Citicoline’s metabolic pathways, please note that this figure has been modified to include: Adibhatla RM, Hatcher JF, Dempsey RJ. Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia. Stroke. 2001;32(10):2376–2381.Read the original article |
format |
article |
author |
Gareri P Castagna A Cotroneo AM Putignano S De Sarro G Bruni AC |
author_facet |
Gareri P Castagna A Cotroneo AM Putignano S De Sarro G Bruni AC |
author_sort |
Gareri P |
title |
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum] |
title_short |
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum] |
title_full |
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum] |
title_fullStr |
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum] |
title_full_unstemmed |
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum] |
title_sort |
role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [corrigendum] |
publisher |
Dove Medical Press |
publishDate |
2015 |
url |
https://doaj.org/article/7dae5f0708694c12a78b84b1504d1d15 |
work_keys_str_mv |
AT garerip theroleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum AT castagnaa theroleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum AT cotroneoam theroleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum AT putignanos theroleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum AT desarrog theroleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum AT bruniac theroleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum AT garerip roleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum AT castagnaa roleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum AT cotroneoam roleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum AT putignanos roleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum AT desarrog roleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum AT bruniac roleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum |
_version_ |
1718399410746949632 |